Bathi sadurunge mbayar bunga, pajak, lan amortisasi: foghorntx.com (FHTX)

Foghorn Therapeutics (FHTX) develops innovative oncology treatments through gene regulation. On the GURU.Markets platform, the EBITDA trend demonstrates the efficiency of core operations, with the latest value recorded as 10.44. This sector is not subject to market cycles or seasonality. Financial stability is maintained through strategic partnerships that offset R&D costs.

Bathi sadurunge mbayar bunga, pajak, lan amortisasi Foghorn Therapeutics Inc. (FHTX): kanggo periode 23.11.2025 - 12.11.2026

Foghorn Therapeutics Inc. (FHTX) - rincian metrik lan laporan keuangan

- rega saham lan target rega konsensus:

Bagan rega Foghorn Therapeutics, Inc.|FHTX - Bagan rega target

- indikator kapitalisasi bursa perusahaan:

Nilai pasar Foghorn Therapeutics|FHTX - Nilai Total Perusahaan

- rincian valuasi buku bisnis:

Nilai Aset Bersih saben Saham Foghorn Therapeutics|FHTX - Nilai Buku Perusahaan|Koefisien Nilai Pasar marang Nilai Buku foghorntx.com|FHTX - Total Aset Perusahaan

- data tingkat utang lan likuiditas finansial:

Rasio Utang marang Ekuitas Foghorn Therapeutics|FHTX - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang ekuitas Foghorn Therapeutics, Inc.|FHTX - Utang perusahaan|Utang-utang marang nilai buku Foghorn Therapeutics|FHTX - Utang jangka dawa perusahaan|Tanggungan jangka cendhak Foghorn Therapeutics|Rasio jangkoan perantara foghorntx.com

- rincian bathi lan kelipatan pasar:

FHTX - Bathi resik perusahaan|Bathi resik sing dikarepake Foghorn Therapeutics|FHTX - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi Foghorn Therapeutics, Inc.|FHTX - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Foghorn Therapeutics|FHTX - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku Foghorn Therapeutics|FHTX - Bathi resik saben saham sajrone 12 wulan pungkasan|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan foghorntx.com|FHTX - Wutah bathi ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Foghorn Therapeutics

Analisis kabeh metrik perusahaan:Foghorn Therapeutics

Barang unggulan Foghorn Therapeutics Inc.

Foghorn Therapeutics (FHTX) maintains its status as a reputable developer in the field of chromatin biology through strategic partnerships with major pharmaceutical companies. By analyzing the dynamics of gross operating profit before depreciation and amortization, an investor assesses the business's actual ability to generate cash regardless of debt load and amortization, which allows for a real-time assessment of cash flow changes and determines the company's fundamental resilience to market shocks.

Karo sapa Foghorn Therapeutics saingan